Nebius signs AI capacity deal with Meta-March 2024-www.financetom.com

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Nebius signs AI capacity deal with Meta

Mar 16, 2026 3:27 AM

March 16 (Reuters) - Nebius Group ( NBIS ) said on

Monday it has signed a new five-year deal with Meta Platforms ( META )

to provide the social media giant with $12 billion of

dedicated AI capacity across multiple locations.

The agreement has a contract value of up to $27 billion, the

company said.

Previous page： Atlassian Insider Sold Shares Worth $1,604,286, According to a Recent SEC Filing Next page： Alaska Air Group says 737 Max 9 grounding may hit long-term profit growth

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Atlassian Insider Sold Shares Worth $1,604,286, According to a Recent SEC Filing

Mar 28, 2024

06:01 PM EDT, 03/28/2024 (MT Newswires) -- Scott Farquhar, 10% Owner, Director, Co-CEO, Co-Founder, on March 28, 2024, sold 8,241 shares in Atlassian ( TEAM ) for $1,604,286. SEC Filing: https://www.sec.gov/Archives/edgar/data/1650372/000156218024003039/xslF345X03/primarydocument.xml Price: 194.92, Change: -0.19, Percent Change: -0.1 ...

Alaska Air Group says 737 Max 9 grounding may hit long-term profit growth

Mar 28, 2024

(Reuters) -Alaska Air Group ( ALK ) said on Thursday the lost capacity from the temporary grounding of its Boeing 737 Max 9 fleet may cause the company's long-term profit growth to be below its target range of 4% to 8%. Earlier this month, Alaska Air ( ALK ) forecast first-quarter adjusted loss per share of 55 cents to 45...

Bristol Myers' bowel disease drug fails in late-stage study

Mar 28, 2024

March 28 (Reuters) - Bristol Myers Squibb ( BMY ) said on Thursday its experimental drug to treat Crohn's disease, a chronic inflammatory bowel condition, did not help patients achieve disease remission in a late-stage study. Crohn's is a chronic bowel disease that causes inflammation in the digestive tract, and can lead to diarrhea, abdominal pain, fatigue and weight loss....

Sera Prognostics Insider Sold Shares Worth $727,853, According to a Recent SEC Filing

Mar 28, 2024

06:01 PM EDT, 03/28/2024 (MT Newswires) -- John J. Boniface, Chief Scientific Officer, on March 27, 2024, sold 77,136 shares in Sera Prognostics ( SERA ) for $727,853. Following the Form 4 filing with the SEC, Boniface has control over a total of 139,771 shares of the company, with 139,771 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1534969/000153496924000073/xslF345X03/wk-form4_1711662978.xml ...